Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 27, 2017 16:01 ET | Source: Dynavax Technologies

Dynavax to Present at the Evercore ISI Biopharma Catalyst/Deep Dive Conference

BERKELEY, CA--(Marketwired - November 27, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that Eddie Gray, Dynavax's chief executive officer, will present at the Evercore ISI...
November 09, 2017 16:45 ET | Source: Dynavax Technologies

Dynavax Announces FDA Approval of HEPLISAV-B(TM) for Prevention of Hepatitis B in Adults

BERKELEY, CA--(Marketwired - November 09, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved HEPLISAV-B [Hepatitis...
November 03, 2017 06:30 ET | Source: Dynavax Technologies

Dynavax Reports Third Quarter 2017 Financial Results

BERKELEY, CA--(Marketwired - November 03, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the third quarter ended September 30, 2017. Cash, cash...
October 19, 2017 06:30 ET | Source: Dynavax Technologies

Dynavax Initiates Clinical Trial in Non-Small Cell Lung Cancer with a Novel Inhaled TLR9 Agonist in Combination with Anti-PD-1 Therapy

BERKELEY, CA--(Marketwired - October 19, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced initiation of dosing in a phase 1B dose escalation clinical trial of its investigational...
September 05, 2017 06:00 ET | Source: Dynavax Technologies

Dynavax to Present at Upcoming Investor Conferences

BERKELEY, CA--(Marketwired - September 05, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that the company will present at two upcoming investor conferences in...
August 15, 2017 16:01 ET | Source: Dynavax Technologies

Dynavax Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock

BERKELEY, CA--(Marketwired - August 15, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced the completion of an underwritten public offering of 5,750,000 shares of its common...
August 09, 2017 20:00 ET | Source: Dynavax Technologies

Dynavax Prices Public Offering of Common Stock

BERKELEY, CA--(Marketwired - August 09, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced the pricing of a previously announced underwritten public offering of 5,000,000 shares...
August 08, 2017 16:05 ET | Source: Dynavax Technologies

Dynavax Announces Proposed Public Offering of Common Stock

BERKELEY, CA--(Marketwired - August 08, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it intends to offer and sell $125.0 million of shares of its common stock, subject...
August 03, 2017 16:00 ET | Source: Dynavax Technologies

Dynavax Provides U.S. Regulatory Update on HEPLISAV-B(TM) Following FDA Advisory Committee Meeting

BERKELEY, CA--(Marketwired - August 03, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has requested more detailed...
August 02, 2017 06:00 ET | Source: Dynavax Technologies

Dynavax Reports Second Quarter 2017 Financial Results

BERKELEY, CA--(Marketwired - August 02, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the second quarter ended June 30, 2017. Cash, cash equivalents and...